Can this procedure in which screened and processed feces is transferred from a healthy donor to a patient also be used in other set- tings to increase intestinal microbial diversity and restore a normal protective microbiome In a feature article in this month's issue of Gastroenterology  Hepatology Dr Robert J. Gianotti and Dr Alan C. Moss review the use of fecal microbiota transplantation in patients with C difficile infection and examine the procedure's potential in patients with inflammatory bowel disease IBD.Fecal microbiota transplantation is also discussed in a Clinical Update column on the evidence-based approach to managing patients with initial or recurrent C difficile infection.

Dr Stuart Johnson reviews the data currently available on this procedure as well as other treatment options for C difficile infection including metronidazole vancomycin fidaxomicin and the recently approved agent bezlotoxumab.In another feature article Dr Kalyan Ram Bhamidimarri Dr Sanjaya K. Satapathy and Dr Paul Martin examine the management of hepatitis C virus HCV infection before during and after liver trans- plantation.

 LETTER FROM THE EDITOR Fecal Microbiota Transplantation An Updatence considered a medical curiosity fecal micro- biota transplantation is starting to become a fairly widespread practice for the treatmentof Clostridium difficile infection.

As the authors note HCV infection is the leading cause of liver transplantation in the United States.

However treatment for HCV infection in the setting of liver transplantation is not one-size-fits-all.

